Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs
Dong-Kun YANG; Ha-Hyun KIM; Jae-Young YOO; Miryeon JI; Bok-Hee HAN; Subin OH; Bang-Hun HYUN.
Clinical and Experimental Vaccine Research
; : 40-47, 2020.
Artículo en Inglés | WPRIM | ID: wpr-782293
Documentos relacionados
The biological characteristics of the canine adenovirus type 1 from fox and the transcriptome analysis of the infected MDCK cell.
Production of canine adenovirus type 2 in serum-free suspension cultures of MDCK cells.
Impact of adenovirus life cycle progression on the generation of canine helper-dependent vectors.
Cell Bank Origin of MDCK Parental Cells Shapes Adaptation to Serum-Free Suspension Culture and Canine Adenoviral Vector Production.
A simplified system for generating recombinant E3-deleted canine adenovirus-2.
The serological and virological investigation of canine adenovirus infection on the dogs.
Difference Analysis Between Canine Adenovirus Types 1 And 2.
Investigation of canine chaphamaparvovirus, canine bufavirus, and canine adenovirus in dogs with diarrhea: First report of novel canine bufavirus in Turkey.
Direct evidence of fiber-protein-directed hemagglutination by canine adenoviruses.
An Oil-Based Adjuvant Improves Immune Responses Induced by Canine Adenovirus-Vectored Vaccine in Mice.